| Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography imaging JG Rajendran, DA Mankoff, F O’Sullivan, LM Peterson, DL Schwartz, ... Clinical cancer research 10 (7), 2245-2252, 2004 | 430 | 2004 |
| In vivo validation of 3′ deoxy-3′-[18F] fluorothymidine ([18F] FLT) as a proliferation imaging tracer in humans: correlation of [18F] FLT uptake by positron emission … H Vesselle, J Grierson, M Muzi, JM Pugsley, RA Schmidt, P Rabinowitz, ... Clinical cancer research 8 (11), 3315-3323, 2002 | 380 | 2002 |
| Imaging P‐glycoprotein transport activity at the human blood‐brain barrier with positron emission tomography L Sasongko, JM Link, M Muzi, DA Mankoff, X Yang, AC Collier, ... Clinical Pharmacology & Therapeutics 77 (6), 503-514, 2005 | 303 | 2005 |
| Regional hypoxia in glioblastoma multiforme quantified with [18F] fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and … AM Spence, M Muzi, KR Swanson, F O'Sullivan, JK Rockhill, ... Clinical Cancer Research 14 (9), 2623-2630, 2008 | 267 | 2008 |
| 18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter AM Spence, M Muzi, DA Mankoff, SF O’Sullivan, JM Link, TK Lewellen, ... Journal of Nuclear Medicine 45 (10), 1653-1659, 2004 | 188 | 2004 |
| Kinetic analysis of 3′-deoxy-3′-fluorothymidine PET studies: validation studies in patients with lung cancer M Muzi, H Vesselle, JR Grierson, DA Mankoff, RA Schmidt, L Peterson, ... Journal of Nuclear Medicine 46 (2), 274-282, 2005 | 183 | 2005 |
| Tumor-specific positron emission tomography imaging in patients:[18F] fluorodeoxyglucose and beyond DA Mankoff, JF Eary, JM Link, M Muzi, JG Rajendran, AM Spence, ... Clinical cancer research 13 (12), 3460-3469, 2007 | 167 | 2007 |
| Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomas MD Szeto, G Chakraborty, J Hadley, R Rockne, M Muzi, EC Alvord, ... Cancer research 69 (10), 4502-4509, 2009 | 154 | 2009 |
| 18F-FDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy J Tseng, LK Dunnwald, EK Schubert, JM Link, S Minoshima, M Muzi, ... Journal of Nuclear Medicine 45 (11), 1829-1837, 2004 | 150 | 2004 |
| Kinetic analysis of 3′-deoxy-3′-18F-fluorothymidine in patients with gliomas M Muzi, AM Spence, F O'Sullivan, DA Mankoff, JM Wells, JR Grierson, ... Journal of Nuclear Medicine 47 (10), 1612-1621, 2006 | 146 | 2006 |
| Imaging of cyclosporine inhibition of P-glycoprotein activity using 11C-verapamil in the brain: studies of healthy humans M Muzi, DA Mankoff, JM Link, S Shoner, AC Collier, L Sasongko, ... Journal of Nuclear Medicine 50 (8), 1267-1275, 2009 | 133 | 2009 |
| Complementary but distinct roles for MRI and 18F-fluoromisonidazole PET in the assessment of human glioblastomas KR Swanson, G Chakraborty, CH Wang, R Rockne, HLP Harpold, M Muzi, ... Journal of nuclear medicine 50 (1), 36-44, 2009 | 132 | 2009 |
| Kinetic modeling of 3′-deoxy-3′-fluorothymidine in somatic tumors: mathematical studies M Muzi, DA Mankoff, JR Grierson, JM Wells, H Vesselle, KA Krohn Journal of Nuclear Medicine 46 (2), 371-380, 2005 | 131 | 2005 |
| Glucose metabolism in human malignant gliomas measured quantitatively with PET, l-[C-ll] glucose and FDG: analysis of the FDG lumped constant AM Spence, M Muzi, MM Graham, F O'Sullivan, KA Krohn, JM Link, ... Journal of Nuclear Medicine 39 (3), 440-448, 1998 | 131 | 1998 |
| Metabolism of 3′-deoxy-3′-[F-18] fluorothymidine in proliferating A549 cells: validations for positron emission tomography JR Grierson, JL Schwartz, M Muzi, R Jordan, KA Krohn Nuclear medicine and biology 31 (7), 829-837, 2004 | 128 | 2004 |
| Hypoxia imaging-directed radiation treatment planning JG Rajendran, KRG Hendrickson, AM Spence, M Muzi, KA Krohn, ... European journal of nuclear medicine and molecular imaging 33 (1), 44-53, 2006 | 117 | 2006 |
| Kinetic analysis of 2-[11C] thymidine PET imaging studies: validation studies DA Mankoff, AF Shields, JM Link, MM Graham, M Muzi, LM Peterson, ... Journal of Nuclear Medicine 40 (4), 614-624, 1999 | 106 | 1999 |
| Verapamil P-glycoprotein transport across the rat blood-brain barrier: cyclosporine, a concentration inhibition analysis, and comparison with human data P Hsiao, L Sasongko, JM Link, DA Mankoff, M Muzi, AC Collier, ... Journal of Pharmacology and Experimental Therapeutics 317 (2), 704-710, 2006 | 103 | 2006 |
| Variations of dynamic contrast-enhanced magnetic resonance imaging in evaluation of breast cancer therapy response: a multicenter data analysis challenge W Huang, X Li, Y Chen, X Li, MC Chang, MJ Oborski, DI Malyarenko, ... Translational oncology 7 (1), 153-166, 2014 | 100 | 2014 |
| True tracers: comparing FDG with glucose and FLT with thymidine KA Krohn, DA Mankoff, M Muzi, JM Link, AM Spence Nuclear medicine and biology 32 (7), 663-671, 2005 | 99 | 2005 |
Jashvant UnadkatVerified email at uw.edu
